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Giovanni Battista Luciani, MD, Alessandro Favaro, MD, Francesca Viscardi, MD, Paolo Bertolini, MD, and
Alessandro Mazzucco, MD, Verona, ItalyAortic valve replacement with the pulmonary autograft(ie, the Ross operation) is generally associated withsatisfactory early and late results. Complications,however, can occur, including the tendency of the
pulmonary autograft root to dilate with time.1 Whereas neoaortic
root dilatation might be observed in as many as one third of
patients late after the Ross operation,2 uncertainty still exists as to
the rate of progression toward true aneurysmal disease (aortic
diameter 5 cm).1,2 Furthermore, the actual risk of complications,
such as neoaortic rupture or dissection, is also unknown. The yet
undefined natural history of root dilatation after the Ross opera-
tion, the often satisfactory competence of the pulmonary autograft
valve, the scarcity of valid therapeutic alternatives (particularly in
the infant and child), and the complexity–risk of reintervention
have thus far delayed standardization of therapeutic indications. In
particular, timing and technique of reoperation on the aneurysmal
neoaortic root are still controversial.1,2
Here we present a case of potentially lethal evolution of pro-
gressive pulmonary autograft dilatation (ie, neoaortic root dissec-
tion) successfully treated with valve-sparing root replacement. The
implications in terms of natural history and indications for rein-
tervention are discussed.
Clinical Summary
A 29-year-old man with a long-standing history of aortic valve
regurgitation on the bicuspid aortic valve and mild dilatation of the
aortic root underwent elective aortic root replacement with the
pulmonary autograft on October 18, 1994. The right ventricular
outflow tract was reconstructed with a 28-mm pulmonary ho-
mograft. Postoperative recovery was uneventful, and discharge
echocardiography showed competent semilunar valves and normal
aortic root diameter. Two years after the operation, moderate
dilatation of the aortic root (maximum diameter, 46 mm) was
identified at yearly echocardiographic examination. The aortic
valve, however, was competent, and the patient was completely
symptom free. Subsequent examinations confirmed progressive
root dilatation, which reached true aneurysmal dimensions 8 years
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The Journal of Thoraciafter the operation. The latest measurement showed a left ventric-
ular aortic junction (aortic annulus) diameter of 32 mm, a sinus of
Valsalva diameter of 48 mm, and a sinotubular junction and
proximal ascending aortic diameter of 54 mm. The aortic valve
presented with mild regurgitation, and mild obstruction of the
pulmonary homograft (peak pressure gradient of 24 mm Hg) was
also identified. Although the patient remained asymptomatic, elec-
tive resection of the root aneurysm was recommended, and pre-
operative angiographic examination was scheduled. On admission
for preoperative screening on July 16, 2003, the patient reported
the recent onset of mild exertional dyspnea.
Repeat echocardiographic examination of the aortic root sug-
gested a further increase in maximum root diameter (63 mm at the
sinus of Valsalva portion), with the presence of an intimal flap
image. Aortic valve function had worsened to produce moderate
insufficiency, and mild dilatation of the left ventricle (left ventric-
ular end-diastolic dimension of 65 mm) with normal systolic
function (ejection fraction of 65%) was also present. These find-
ings were corroborated by means of aortic angiography, showing
severe aortic root dilatation with straightening of the posterior
profile of the root, which suggested the presence of an intimal flap
(Figure 1). Valve insufficiency was graded as mild, and the results
of coronary angiography were normal. Magnetic resonance scan-
ning of the ascending aorta confirmed the diagnosis of aortic root
aneurysm, with dissection limited to the root itself. The distal
ascending aorta, the arch, and the descending thoracic aorta were
unremarkable. Given the likelihood of acute or subacute neoaortic
root dissection, the patient was transferred to our unit for urgent
repair. On sternal re-entry, marked dilatation of the aortic root was
identified. By using mildly hypothermic cardiopulmonary bypass,
the distal ascending aorta was crossclamped, and the heart was
arrested with retrograde blood cardioplegia. After transection of
the aorta at the level of the distal aortic anastomosis, marked
thinning of the aortic root wall was evident. An intimal flap
extending from the level of the aortotomy to the noncoronary sinus
of Valsalva was found. The left and right coronary sinuses were
intact.
Because the pulmonary autograft valve appeared normal, aortic
root remodeling with the Yacoub technique was performed with a
size 30 Dacron graft. After weaning from cardiopulmonary bypass,
intraoperative transesophageal echocardiography showed only
trace aortic insufficiency. Postoperative recovery proved unevent-
ful, with discharge on the seventh postoperative day without car-
diac medication. Histologic examination of the pulmonary au-
tograft wall demonstrated cystic medial necrosis, with
fragmentation and loss of elastic fibers and moderate deposition of
mucopolysaccharide material (Figure 2). On follow-up examina-
tion, the patient is in New York Heart Association class I and
presents with mild autograft aortic valve insufficiency, with an
aortic annulus diameter of 30 mm, a sinus of Valsalva and sino-
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Brief Communicationstubular junction diameter of 36 mm, and a proximal ascending
aorta diameter of 34 mm on the latest echocardiographic assess-
ment 6 months after reoperation.
Discussion
Despite widespread satisfaction with the clinical outcome of the
Ross operation, awareness of its early and late shortcomings is
Figure 1. Left anterior oblique (A) and right anterior obl
dilatation is apparent. An intimal flap limited to the aor
of the posterior border of the aortic root.
Figure 2. Histology of the resected pulmonary autogra
deposition of mucopolysaccharide material (hematox
original magnification 200).growing.1,2 Neoaortic root dilatation has since emerged as the
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implanted with the complete root replacement technique.1,2 The
proportion of patients with root dilatation who show progression
toward true neoaortic aneurysm (aortic diameter 5 cm) and the
rate of progression are matters of controversy.1,2 Quite clearly,
however, progressive autograft root dilatation has been shown to
cause neoaortic valve insufficiency.2,3 This observation explains
(B) view of aortic root angiogram. Severe (>6 cm) root
ot can be suspected on the basis of the straightening
t wall showing cystic medial necrosis with moderate
and eosin stain; A, original magnification 100; B,ique
tic roft roothe increasing number of recent reports on elective reoperations for
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Brief Communicationsautograft root aneurysm.3-8 Therapeutic indications with regard to
timing and technique of reintervention have thus far been elu-
sive.1,2 Several factors account for the absence of standardized
criteria for reoperation, including the undefined natural history of
autograft root dilatation, the possible coexistence of a competent
neoaortic valve, the scarcity of valid surgical alternatives, and the
complexity of redo aortic root procedures with the attendant mor-
bidity.9 In general, elective intervention on the neoaortic root has
been advised in the presence of moderate or severe neoaortic valve
insufficiency or when the aortic root diameter exceeded 55
mm.1,3-8 Some authors have also deferred reintervention on the
basis of the severity of concomitant pulmonary homograft dys-
function, with the intent to minimize the number of reoperations.4
The technique most commonly adopted to replace the dilated
aortic root has been the modified Bentall operation using compos-
ite mechanical or biologic grafts, with valve-sparing root replace-
ment limited to anecdotal reports.4-8 By using this approach,
morbidity associated with reoperation has been low. However, the
proportion of patients benefiting from neoaortic valve preservation
has also proved low, as low as one third of those requiring
reintervention.4 Our initial approach to the problem of root aneu-
rysm after the Ross procedure has been cautious, thereby delaying
reoperation until the appearance of moderate valve insufficiency
and progressive left ventricular enlargement. This has resulted in
only 1 of 3 patients, the present one, having successful root
remodeling with valve preservation (Table 1). The case here re-
ported provides evidence that progressive neoaortic root dilatation
after the Ross procedure might be complicated by aortic root
dissection. From a clinical and histologic standpoint, the presen-
tation is identical to that of native aortic dissection. However,
involvement is limited to the aortic root by the distal anastomotic
suture line. Whereas brachiocephalic and thoracoabdominal aortic
collaterals will be protected by the disease process, any proximal
aortic complication is possible, including aortic valve regurgita-
tion, coronary occlusion, or aortic rupture. Although clinically
relevant valve insufficiency appeared subtly in the case herein, the
untoward events reported above can all occur acutely. Given the
TABLE 1. Patients undergoing resection of aortic aneurys
Age (y),
sex (M/F) Original disease Ross technique
Interval
after Ross
operation
(y)
31, M AS, AI, bicuspid Root replacement,
sinus obliteration
technique
7
38, M AI, tricuspid Root replacement,
inflow-outflow
pericardial
support
6
38, M AI, bicuspid Root replacement 9
AS, Aortic stenosis; AI, aortic insufficiency; CMN, cystic medial necrosis;impossibility to quantify the risk of neoaortic root rupture and the
The Journal of Thoraciyoung age of the patient, indication for reintervention was thus
planned on an urgent basis, even in the absence of marked clinical
symptomatology. Contrary to the attitude thus far adopted, early
treatment of neoaortic root dilatation deserves consideration re-
gardless of valve function because life-threatening complications,
such as neoaortic root dissection, are a definite risk.
Similar to previous reports,4,7 histologic examination of the
excised pulmonary artery wall has demonstrated cystic medial
necrosis, with fragmentation and loss of elastic fibers and deposi-
tion of mucopolysaccharides. Some authors have proposed that
such changes might be related to congenital alteration of the
pulmonary artery trunk in patients with bicuspid aortic valve
disease.10 However, identical lesions have been observed in the
pulmonary artery wall of patients with tricuspid aortic valves
undergoing post-Ross aortic aneurysm resection at our institution
(Table 1), as well as at others.7 These findings agree with prior
echocardiographic results showing no correlation between neoaor-
tic root dilation and bicuspid aortic valve disease.2 Further studies
are warranted to define whether autograft root pathology is linked
to congenital rather than acquired factors (eg, exposure to systemic
pressure or interruption of vasa vasorum).
On the basis of the present report, life-threatening complica-
tions of neoaortic root aneurysm, such as dissection or even
rupture, are distinct possibilities. Elective resection of the autograft
root aneurysm should not be delayed until evidence of valve
involvement shows but rather scheduled prophylactically in rela-
tion to morphometric parameters, as suggested for the native aortic
aneurysm in patients with Marfan syndrome or bicuspid aortic
valve disease.11 Earlier indication for reoperation might reduce the
risk of spontaneous neoaortic root complications and increase the
likelihood of autograft valve preservation.
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Metastatic left atrial synovial sarcoma mimicking a myxoma
Sanjay Kumar, MCh, FRCS,a Mubarak A. Chaudhry, FRCS,a Irfan Khan, MRCS,a David J. R. Duthie, MD, FRCA,b,a Leeds and Bradford, United KingdomHeart neoplasms are of increasing interest to cliniciansand surgeons. A synovial sarcoma of the heart, eitherprimary or secondary in origin, is extremely uncom-mon.1 To our knowledge, this report is the first doc-
umented metastatic synovial sarcoma of the left atrium and em-
phasizes that this tumor, although rare, should be considered in the
differential diagnosis of left atrial myxoma. The pathology, clini-
cal implication, and management options are discussed.
Clinical Summary
A 27-year-old man presented with a 4-month history of palpita-
tions and dyspnea. Of note, there was no history of syncope,
constitutional symptoms, or previous asbestos exposure. Within
the last few weeks, he had also noticed a tender swelling in his
right calf. Apart from the presence of the calf swelling, his phys-
ical examination was unremarkable. Transthoracic echocardiogra-
phy showed a 4  2.5–cm mass arising from the mitral valve and
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consistent with that of a myxoma, although its site of origin was
unusual.
The patient was admitted expeditiously for excision of the left
atrial mass. Through a median sternotomy, cardiopulmonary by-
pass was established after aortobicaval cannulation. The heart was
arrested with antegrade cold blood cardioplegia. An atriotomy was
made in a large left atrium behind the interatrial groove. A large 3
 3.5–cm, dumbbell-shaped mass was present in the left atrium.
It had a wide origin, arising from the posterior mitral leaflet,
posteromedial commissure, adjoining anterior mitral leaflet, and
left atrial wall posteriorly. The mass (Figure 2) could not be
excised without sacrificing the mitral valve, which was replaced
with a 29-mm St Jude mechanical prosthesis. There was a possi-
bility of incomplete resection because the tumor was invading the
atrioventricular groove. The patient had an uneventful postopera-
tive recovery.
The histopathologic examination revealed a tumor of mixed
cellularity set within focally calcified fibrous stroma–positive mar-
gin. Morphologic and immunocytochemical features of the tumor
were consistent with the diagnosis of synovial sarcoma. A cyto-
genetic examination of the excised lesion demonstrated an abnor-
mal triploid clone containing 2 copies of translocation t(X; 18),
which is consistent with the above diagnosis.
After histologic diagnosis of the cardiac tumor, the patient
underwent a contrast spiral computed tomographic scan of the
thorax, abdomen, and pelvis. No further intrathoracic or intra-
abdominal lesion was seen. An ultrasound scan of the right calf
swelling suggested a discrete lesion with its own intrinsic blood
flow, which is consistent with it being a sarcoma. A tru-cut biopsy
confirmed this to be a synovial sarcoma. Which lesion, either left
atrial or right calf, was the primary and which was the secondary
was impossible to determine both histologically and clinically. The
mber 2004
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Brief Communicationspossibility that both were secondary lesions with an unrecognized
primary source cannot be discounted.
The patient received ifosfamide-based chemotherapy. This
comprised 9 g/m2 ifosfamide every 3 weeks for 2 cycles. A spiral
computed tomographic scan was performed after completing 2
cycles. Two new areas of abnormalities were seen: a 2-mm nodule
in the right lower lobe of the lung and a cluster of small lymph
nodes adjacent to the left kidney. A new subcutaneous soft tissue
swelling was also present in the right loin posteriorly. The patient
was offered second-line chemotherapy with doxorubicin with or
without trial agents, but he elected to explore alternative therapies.
Discussion
Tumors of the heart are rare and are usually benign, with the
majority being myxomas. Only 25% of primary cardiac tumors are
malignant, and nearly all are sarcomas. The most common are
angiosarcomas (31%), followed by rhabdomyosarcomas (21%),
malignant mesotheliomas (15%), and fibrosarcomas (11%), with
synovial sarcomas being extremely rare.1,2 However, the most
common cardiac malignancy is a metastatic cardiac tumor, being
20 to 40 times more common than primary cardiac malignancies.1
The synovial sarcoma itself is an uncommon mesenchymal
malignant tumor with epithelial qualities.1 The most common
primary site for a synovial sarcoma is the lower limb, usually in the
para-articular regions. An occurrence outside the synovial-lined
spaces is rare, and only a limited number of cases have been
documented. They are also known to arise within the abdominal
wall, neck, head, mediastinum, lung, or pleura. On rare occasions,
these are known to arise within the heart.
There are 7 published reports of primary cardiac synovial
sarcomas in patients ranging from 13 to 53 years of age (mean,
40.8 years).1,3 Most of these patients presented with syncope or
dyspnea. There is an association with previous exposure to asbes-
tos.4 These patients might be asymptomatic or might present with
transient ischemic attack, pulmonary hypertension, heart failure, or
cardiac tamponade, symptoms dependent on location within the
Figure 1. Transesophageal echocardiogram showing th
mitral leaflet (AML) in systole; B, protruding through th
diastole. The left ventricle (LV), right atrium (RA), andheart and associated pathology.5-8 Sarcomas present in the left
The Journal of Thoraciatrium can be easily mistaken for left atrial myxomas because
echocardiographically they are indistinguishable.4,5 To date, no
report of a metastatic arial synovial sarcoma has been published.
Because primary synovial sarcomas commonly arise at extracar-
diac sites, it is likely that in this case the calf lesion is the primary
lesion, with metastatic spread to the heart.
The diagnosis of a synovial carcinoma is confirmed by means
of identification of a chromosomal translocation, t(X; 18), which is
found in more than 90% of all synovial sarcomas. The distinction
between a synovial sarcoma and a primary cardiac mesothelioma
of the heart is difficult, and therefore it is important to confirm the
t(X;18) translocation to verify the diagnosis.1,3,4
For primary intracardiac sarcomas with no evidence of meta-
static spread, surgical intervention is the mainstay of treatment not
only to alleviate symptoms but also to avoid potential complica-
Figure 2. The excised tumor is shown, and the arrow points to the
end of the tumor attached to the left atrial wall, the leaflets, and
the posteromedial commissure of the mitral valve.
or (T) in the left atrium (LA): A, attached to the anterior
tral valve orifice close to the anterior mitral leaflet in
ventricle (RV) are also shown.e tum
e mitions. As in this case, excision of a valve might be necessary to
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section is possible in only 33% of patients.9 Invasion of the
atrioventricular groove by tumor in this case made complete re-
section impossible. Recurrence is common even in patients with
apparent complete excision.9 After surgical intervention, adjuvant
radiotherapy for local recurrence and chemotherapy for control of
systemic disease might be considered. Heart-lung transplantation
has been reported as an option for cure in patients with primary
cardiac synovial sarcomas with no evidence of metastatic spread.10
This was not an option in our patient because of the likely meta-
static involvement of the heart.
Synovial sarcoma of the heart is a disease of young people and
carries a poor prognosis. In most reported cases, patients succumb
within 1 year of diagnosis.1 The most common cause of death is
local recurrence (50%), even after complete macroscopic resec-
tion.9 The aggressive nature of the disease might require modifi-
cation of accepted treatment modalities and sequence.
In retrospect, the unusual echocardiographic features (ie, at-
tachment to the mitral leaflet) in our patient should have raised
suspicion. A cardiac magnetic resonance image might have pro-
vided more detailed anatomic information and suggested histolo-
gy.11 It can be argued that the usual paradigm of treating potential
myxomas urgently should have been disregarded, with the calf
lesion investigated first. One cannot help but postulate that cardio-
pulmonary bypass in this instance might have hastened the dis-
semination of the tumor.
Conclusion
Metastatic synovial sarcoma to the left atrium carries a grave
prognosis. It should be considered in the differential diagnosis of
left atrial myxomas, especially if the echocardiography suggests
unusual features.
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